Abstract:OBJECTIVE:To observe the effect of cisplatin alone or combined with anti-programmed death ligand 1 monoclonal antibody (anti-PD-L1 mAb) on the co-culture system of lung adenocarcinoma SPCA-1 cells and T lymphocytes, and therefore to study the immunotherapeutic effect of anti-PD-L1 mAb on lung cancer.METHODS:Human adenocarcinoma SPCA-1 cell line was selected by flow cytometry (FCM) due to its high expression of membranous programmed death ligand-1 (PD-L1). The concentration of cisplatin was determined by CCK-8 method depending on the inhibition rate of SPCA-1 cell, which was set to less-than-or-equal-to 20% (IC20). After treatment with different concentrations of cisplatin, cell proliferation (A value) of SPCA-1 cells and T lymphocytes were detected by CCK-8 method and cell cycle of SPCA-1 cells and cell apoptosis of T lymphocytes were analyzed using PI staining. Treated with different concentrations of cisplatin alone or in combination with anti-PD-L1, T lymphocyte proliferation in co-culture system was determined by CCK-8 method, and cytokines such as IFN (interferon)-γ, IL-2, IL-10 and TNF-α were detected with enzyme linked immunosorbent assay (ELISA) method.RESULTS:The IC20 of cisplatin on SPCA-1 cells was ≤ 0.78 mg/L. The proliferation of SPCA-1 cells were inhibited with different concentrations of cisplatin in a concentration-dependent manner (0.78∼12.5 mg/L) (P < 0.001). Compared with the group treated with high-dose of cisplatin (12.5 mg/L), the proliferation of T lymphocytes treated with low-dose of cisplatin (0.78 mg/L) was higher (t = 3.508, P < 0.05) and the number of late apoptotic and dead T lymphocytes in the co-culture system was reduced (t = 17.55, P < 0.001). Compared with the group of co-culture system, cisplatin (0.78 mg/L) combined with anti-PD-L1 (1.5 mg/L) significantly enhanced the proliferation of T lymphocytes in the co-culture system (t = 4.419, P < 0.01). Also, the levels of T helper cell type-1 (Th1) cytokines such as IFN-γ, IL-2 and TNF-α were up-regulated (t = 25.79-55.15, P < 0.01) and the T helper cell type-2 (Th2) cytokine IL-10 was down-regulated (t = 18.38, P < 0.01).CONCLUSION:Low-dose of cisplatin combined with anti-PD-L1 could effectively promote the proliferation of T lymphocytes in the microenvironment and increase the secretion of Th1 type cytokines. This may reduce the toxic effect of high-dose antineoplastic agents on immune cells and help eradication of tumor cells.

Growth inhibition of NS-398 combined with cisplatin on human lung adenocarcinoma cells and its mechanism]

Study of mechanism in growth inhibition of human lung Study of mechanism in growth inhibition of human lung adenocarcinoma with combined use of NS-398 and cisplatin

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

[Different Proteome of Human Lung Adenocarcinoma Cells Treated with NS-398 and Cisplation].

Mechanism and Effect of Selective Cyclooxygenase-2 Inhibitor NS-398 on Human Cervical Carcinoma Cells

Mechanism and effect of selective cyclooxygenase-2 inhibitor NS-3 9 8 on human cervical carcinoma cells

Synergistic Effect of Gefitinib and Cisplatin on Proliferation of Lung Cancer Cell Line

[Effects of Cyclooxygenase-2 Antisense Vector on Proliferation and Sensitivity to Cisplatin of H1299 Cells].

Intervention Effects of Nedaplatin and Cisplatin on Proliferation and Apoptosis of Human Tumour Cells in Vitro

[Synergistic Effects and Mechanisms of Combined Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Chemotherapeutic Drugs or Radiotherapy in Killing Laryngeal Squamous Carcinoma Cells in Vitro].

The in Vitro Synergistic Cytotoxic Effects of Inductive, Concurrent and Sequential Cyclooxygenase-2 Inhibitor with Cisplatin Against A549 Cell Line

Ns-398 Enhances the Efficacy of Gemcitabine Against Lung Adenocarcinoma Through Up-Regulation of P21(Waf1) and P27(Kip1) Protein

In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines.

Effects of cyclooxygenase-2 inhibitor celecoxib on cyclooxygenase-2 gene expression and cisplatin chemosensitivity in human lung adenocarcinoma A549 cell line

Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells

Effect of Cisplatin Alone or Combined with Monoclonal Anti-Programmed Death Ligand-1 Anti-Body on Lung Adenocarcinoma Cell Line SPCA-1 and T Lymphocytes

Arsenic Trioxide Exerts Synergistic Effects with Cisplatin on Non-Small Cell Lung Cancer Cells Via Apoptosis Induction

PI3K/mTOR inhibitor VS-5584 combined with PLK1 inhibitor exhibits synergistic anti-cancer effects on non-small cell lung cancer

Effects of Zoledronic Acid on Growth of Human Lung Adenocarcinoma Cell Line A549 in Vitro

Inhibition Effect of NS-398 Via COX-2 Dependent and Independent Mechanisms in Human Pancreatic Cancer Cells

Effects of NS398, an inhibitor of cyclooxygenase 2, on the growth and apoptosis of human squamous cell carcinoma cell line Tca8113